Cannabix Technologies, Inc. engages in the development and manufacturing of marijuana breathalyzer technologies for law enforcement, workplaces, and laboratories. The company is headquartered in Burnaby, British Columbia. The company went IPO on 2013-12-16. Breath testing for delta-9 tetrahydrocannabinol (THC) (the primary psychoactive ingredient in cannabis) focuses on marijuana use. The company is engaged in developing novel wall-mounted alcohol screening devices targeted primarily for workplace settings. The company develops contactless breath alcohol detection devices. Its products include Cannabix Marijuana Breath Test (MBT) and BreathLogix Alcohol Breathalyzer. Its breath testing consists of Cannabis Breath Testing and Workplace Alcohol Testing. MBT utilizes a handheld Breath Collection Unit to capture the breath sample into a Cannabix Breath Cartridge that is shipped for laboratory analysis. The BreathLogix alcohol screening product is an autonomous alcohol screening system that enables the screening of employees, contractors and visitors in industries, such as mining, construction, oil and gas, and others.